Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
about
Stabilization of high-risk plaquesOptimizing Treatment of Familial Hypercholesterolemia in Children and AdolescentsEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesMechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskAtherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statinsNovel therapies for the prevention of strokeLDL-Cholesterol: Standards of Treatment 2016: A German Perspective.Model system for the analysis of cell surface expression of human ABCA1.Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patientsFamilial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8)Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.Cholesterol in the retina: the best is yet to come.A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropyRho kinase: an important mediator of atherosclerosis and vascular disease.Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe.Dietary cholesterol: from physiology to cardiovascular risk.Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemiaEzetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis.Dietary cholesterol reverses resistance to diet-induced weight gain in mice lacking Niemann-Pick C1-Like 1.Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signalingEffects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: a single-arm intervention trialDrug therapy of hypercholesterolaemia in children and adolescents.Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trialA whole-body mathematical model of cholesterol metabolism and its age-associated dysregulationLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesUse of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestineAtorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic menPhytosterols and phytosterolemia: gene-diet interactionsRole of the ABCG8 19H risk allele in cholesterol absorption and gallstone diseaseFamilial hypercholesterolemia: current treatment and advances in management.Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.Inactivating mutations in NPC1L1 and protection from coronary heart diseaseEzetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liverEzetimibe for management of hypercholesterolemia.Genetic regulation of cholesterol absorption and plasma plant sterol levels: commonalities and differences.The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia.Pathophysiology of dyslipidaemia in the metabolic syndrome.
P2860
Q26738584-89CD9175-64AE-4662-8017-27558CC1A346Q26798119-65EA304A-82EF-4483-8968-77C2DA3E5C62Q26825467-17CDF1C6-A39A-4A3A-B7C0-68166195DD9BQ27003094-62885B1A-810C-43FB-9AF4-70A8E69C68F6Q28200554-396C9172-8BE9-4A6F-A984-065C758AF542Q28210724-8E097301-2C02-467F-903D-AA73F0D13BC9Q30248925-173731FC-F6D4-4683-A2FE-BBD9053B138DQ33520103-BB9521CF-A111-4BC6-8B7E-26BF55101C22Q33554678-C3CDB839-9BF8-408F-A12E-348EBC86BBE4Q33619852-F2312281-1720-4416-8C42-DAFE475279C4Q33668002-AA8EC574-1C33-4BFE-A542-B7F344DA0596Q33741212-CE2CCBBD-6A15-472B-8732-0D2C9A9FFB63Q33758267-BD68289E-9547-40E9-A7BD-B691FE673627Q33942724-B15BD68D-EF35-43DC-AE7D-860100AC9BC0Q33960556-931C8A40-55D9-4935-9112-66D27543CDA6Q33960580-AED8903A-E4D9-42DF-A0D2-B3E642F481A1Q33984025-1CA40B6F-8EAB-4930-A3B8-72D976DE9AEDQ34026016-9C4EC740-5762-425C-B8FD-BED656C0A4ECQ34049469-A5D09FE3-3C5A-4B39-95B1-29D7E16169A2Q34049540-214E4089-3FD8-4AC9-B7CA-AA7D303F422BQ34113497-47019C3A-6B8B-45E9-A801-B0AB19B5CF0DQ34116347-75C92D73-A29D-4E1F-A97D-2D9A35DCD5E4Q34138315-65519587-1993-43AD-A80C-A4E9B3719C6BQ34217293-C6A9D829-8BD6-4F57-BCAB-32B5A78E6432Q34268963-A00024CC-555E-4EC7-9734-184C1EDCB97CQ34279028-3741723A-3DA9-438D-A879-AC2F7FB5AF99Q34436836-27BCAE95-2C6C-496B-8F0A-723DF22E3593Q34467839-7DE01629-D1C5-4603-9625-B33862D475C1Q34513564-0552FF8F-EDBB-4E36-9804-89438367B581Q34560789-29765357-97A6-43D5-BDFA-7091B4A7383DQ34581638-138DBBDF-E90B-422E-9787-870E777D1B03Q34584897-18594011-2B36-439F-8060-ABD97D27C103Q34769059-2915D0A3-E23E-4456-A780-3CC3461AE7EEQ34812315-03668FAB-05C4-4775-84AD-C6F9EE40EAC0Q35105445-07A033F2-654D-46DC-BFCF-3F82DB066DEDQ35119043-0B5E0F3C-5F4E-429F-8746-0FF781283870Q35139242-CEF6EAFE-0047-4F24-A382-3F8627331781Q35190975-0A6F5A3B-EBA5-4841-88F2-D5D0D40EC849Q35252713-5019F171-EED7-4677-93C2-1B1ACBD97DAAQ35522107-FBFD935C-53B9-420C-AA2C-5143D13C4FDC
P2860
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@en
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@nl
type
label
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@en
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@nl
prefLabel
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@en
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@nl
P2093
P1433
P1476
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
@en
P2093
Annette Kodal
Diane L Tribble
Dieter Lütjohann
Inna Perevozskaya
Klaus von Bergmann
Michael Igel
Sukrut Shah
Thomas Sudhop
P304
P356
10.1161/01.CIR.0000034044.95911.DC
P407
P577
2002-10-01T00:00:00Z